First report of molecular detection of fluoroquinolone resistance-associated <it>gyrA </it>mutations in multidrug-resistant clinical <it>Mycobacterium tuberculosis </it>isolates in Kuwait
<p>Abstract</p> <p>Background</p> <p>Nearly 5% of all <it>Mycobacterium tuberculosis </it>strains worldwide are resistant at least to rifampicin and isoniazid (multidrug-resistant tuberculosis, MDR-TB). Inclusion of a fluoroquinolone and an injectable agent...
Main Authors: | Ahmad Suhail, Al-Mutairi Noura M, Mokaddas Eiman |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-04-01
|
Series: | BMC Research Notes |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1756-0500/4/123 |
Similar Items
-
gyrA Mutations in Fluoroquinolone-resistant Clostridium difficile PCR-027
by: Denise Drudy, et al.
Published: (2007-03-01) -
Molecular detection of fluoroquinolone resistance-associated gyrA mutations in ofloxacin-resistant clinical isolates of Mycobacterium tuberculosis from Iran and Belarus
by: Mohammad Arjomandzadegan, et al.
Published: (2016-01-01) -
Mutational Insights into GyrA and GyrB Genes in Mycobacterium tuberculosis: A Genetic Basis for Fluoroquinolone Resistance in Multidrug-resistant Tuberculosis
by: Anam Shafiq, et al.
Published: (2024-12-01) -
Investigation of gyrA and parC mutations and the prevalence of plasmid-mediated quinolone resistance genes in Klebsiella pneumoniae clinical isolates
by: Sepideh Rezaei, et al.
Published: (2024-07-01) -
Mutations in the gyrA, parC, and mexR genes provide functional insights into the fluoroquinolone-resistant Pseudomonas aeruginosa isolated in Vietnam
by: Nguyen KV, et al.
Published: (2018-02-01)